UnknownNANCT05821634

Digital Phenotyping of Anxiety and Anxiety-Related Alcohol Comorbidity and Treatment

Sponsor: Rutgers, The State University of New Jersey

Trial Details

Condition	Anxiety Disorders and Symptoms, PTSD and Trauma-related Symptoms, Alcohol; Use, Problem; Alcohol Use Disorder
Intervention	Personalized intervention condition: Cognitive behavioral therapy skills; Therapeutic control condition: Cognitive behavioral therapy skills; Tracking control condition: Supportive counseling
Phase	NA
Status	Unknown
Participants	81
Est. Completion	1 June 2027
Last Updated	30 July 2026

Primary Outcome

Change in alcohol related risk; Change in risk drinking levels; Change in anxiety or anxiety-related symptom severity; Change in psychiatric diagnoses

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Access to a smart phone * Between 18 and 65 years * Clinically significant anxiety or trauma-related symptoms * Alcohol use problems * Interest in telehealth counseling * Anticipated New Jersey or New York residence for the duration of the study Exclusion Criteria: * Currently receiving individual counseling or counseling at a higher level of care * Psychiatric medication that is not currently at a stable dose (or is not anticipated to remain at a stable dose for the duration of the study) * Demonstrated indicators of more intensive or acute care * Temporary residence within the state of New Jersey or New York or out-of-state residence from the state of New Jersey or New York

Trial Sites

Countries

United States

View Registry Entry

Related Analysis

Digital Phenotyping Trial Opens: Personalised CBT vs Supportive Counselling for Anxiety-Alcohol Comorbidity — What Clinicians Need to Know

A new Rutgers-sponsored trial is using smartphone-based digital phenotyping to build personalised cognitive behavioural therapy interventions for adults with co-occurring anxiety disorders and alcohol use problems. The three-arm randomised study aims to determine whether real-time, passively collected behavioural data can meaningfully improve treatment outcomes in one of psychiatry's most challenging comorbidities. Australian clinicians working in addiction and mental health should monitor this trial closely for its implications for precision psychiatry and telehealth-delivered care.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service